tiprankstipranks
Trending News
More News >
Enveric Biosciences, Inc. (ENVB)
:ENVB
US Market

Enveric Biosciences (ENVB) Stock Forecast & Price Target

Compare
521 Followers
See the Price Targets and Ratings of:

ENVB Financial Forecast

ENVB Earnings Forecast

The previous quarter’s earnings for ENVB were -$1.22.
The previous quarter’s earnings for ENVB were -$1.22.
No data currently available

ENVB Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ENVB
Vernon BernardinoH.C. Wainwright
H.C. Wainwright
$10
Buy
726.45%
Upside
Reiterated
03/06/25
Promising Developments and Patent Milestone Bolster Buy Rating for Enveric BiosciencesOur $10 PT was derived by using a 13% rate to discount free cash flows from annual sales and payments from a prospective partner’s commercialization of EB-003, and dividing them by our projected number of shares for each year to account for the effects of share dilution, and then factoring in a 2% terminal growth rate and 25% clinical program probability of success.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ENVB
Vernon BernardinoH.C. Wainwright
H.C. Wainwright
$10
Buy
726.45%
Upside
Reiterated
03/06/25
Promising Developments and Patent Milestone Bolster Buy Rating for Enveric BiosciencesOur $10 PT was derived by using a 13% rate to discount free cash flows from annual sales and payments from a prospective partner’s commercialization of EB-003, and dividing them by our projected number of shares for each year to account for the effects of share dilution, and then factoring in a 2% terminal growth rate and 25% clinical program probability of success.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Enveric Biosciences

1 Month
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+22.15%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +22.15% per trade.
3 Months
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
-7.35%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -7.35% per trade.
1 Year
Vernon BernardinoH.C. Wainwright
Success Rate
0/2 ratings generated profit
0%
Average Return
-52.20%
reiterated a buy rating 3 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -52.20% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-63.40%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -63.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ENVB Analyst Recommendation Trends

Rating
May 22
Jun 22
Nov 22
Jan 24
Mar 25
Strong Buy
0
0
0
0
1
Buy
2
2
3
3
2
Hold
1
1
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
In the current month, ENVB has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ENVB average Analyst price target in the past 3 months is 10.00.
Each month's total comprises the sum of three months' worth of ratings.

ENVB Stock Forecast FAQ

What is ENVB’s average 12-month price target, according to analysts?
Based on analyst ratings, Enveric Biosciences, Inc.’s 12-month average price target is 10.00.
    What is ENVB’s upside potential, based on the analysts’ average price target?
    Enveric Biosciences, Inc. has 726.45% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ENVB a Buy, Sell or Hold?
          Enveric Biosciences, Inc. has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Enveric Biosciences, Inc.’s price target?
            The average price target for Enveric Biosciences, Inc. is 10.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $10.00 ,the lowest forecast is $10.00. The average price target represents 726.45% Increase from the current price of $1.21.
              What do analysts say about Enveric Biosciences, Inc.?
              Enveric Biosciences, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of ENVB?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis